Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/10/2005CA2564390A1 Il-6 for therapy or prevention of chemotherapy-induced neuropathy
11/10/2005CA2564179A1 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005CA2564177A1 Caspase-2 inhibitors and their biological applications
11/10/2005CA2564169A1 Methods for preventing or treating bone disorders
11/10/2005CA2563849A1 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy
11/10/2005CA2563828A1 Improved method for identifying peptides in a biological sample
11/10/2005CA2562411A1 Compounds for enzyme inhibition
11/10/2005CA2562181A1 A protein involved in cancer
11/10/2005CA2559918A1 Liquid growth hormone formulation
11/09/2005EP1593740A1 Method of screening anti-obestic medicine, and obesity model animal
11/09/2005EP1593689A2 Myostatin and mimetics thereof
11/09/2005EP1593687A2 Human genes differentially expressed in colon cancer
11/09/2005EP1593686A1 Antineoplastic peptides
11/09/2005EP1593685A1 Peptide antioxidants from soy protein
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593393A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases
11/09/2005EP1593391A1 Remedy for degenerative intervertebral discs
11/09/2005EP1593390A1 Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
11/09/2005EP1593389A1 Pharmaceutical composition comprising a factor VIIa and a factor XIII
11/09/2005EP1593388A1 Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
11/09/2005EP1593387A1 Compositions for the treatment of impaired interpersonal and behavioral disorders
11/09/2005EP1593386A1 Use of galectin-2
11/09/2005EP1593385A1 Use of histones for the early diagnosis and/or preventive therapy of virus-infected living cells and a biochip for implementation of the diagnosis
11/09/2005EP1593384A2 Compositions for treatment of sexual dysfunction
11/09/2005EP1593377A1 Crosslinkable macromers bearing initiator groups
11/09/2005EP1592811A2 Methods for monitoring drug activities in vivo
11/09/2005EP1592808A2 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
11/09/2005EP1592796A2 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2005EP1592795A2 Oligomeric compounds for the modulation of ras expression
11/09/2005EP1592787A2 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE
11/09/2005EP1592786A2 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592709A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
11/09/2005EP1592706A2 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
11/09/2005EP1592704A2 Leukocyte stimulating peptides
11/09/2005EP1592702A2 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
11/09/2005EP1592476A1 Methods for the purification of stable radioiodine conjugates
11/09/2005EP1592449A2 Sensitizing cells for apoptosis by selectively blocking cytokines
11/09/2005EP1592446A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries
11/09/2005EP1592445A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
11/09/2005EP1592439A1 Albumin solution and method for the production thereof
11/09/2005EP1592438A2 Night-time oral insulin therapy
11/09/2005EP1592437A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
11/09/2005EP1592436A2 COMPOUNDS THAT BIND P2Y sb 2 /sb OR P2Y sb 1 /sb RECEPTORS
11/09/2005EP1592435A1 Ophthalmic formulation for the prevention and treatment of ocular conditions
11/09/2005EP1592434A1 Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
11/09/2005EP1592429A1 Method for inhibition of necrosis induced by neurotrophin
11/09/2005EP1592412A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes
11/09/2005EP1592391A2 Tra16 a tr4/tr2 repressor
11/09/2005EP1592387A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592386A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592385A2 Lactate dehydrogenase as a novel target and reagent for diabetes therapy
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1592383A2 Methods for reducing mortality associated with acute myocardial infarction
11/09/2005EP1592373A2 Freeze-dried fibrin matrices and methods for preparation thereof
11/09/2005EP1592312A2 Preparation and food product comprising an active phytase
11/09/2005EP1549334A4 A pharmaceutical composition comprising a retro-iverso isomer pettide
11/09/2005EP1458241A4 Modified antigen-presenting cells
11/09/2005EP1416953A4 Methods of treating liver fibrosis
11/09/2005EP1414370A4 Dry hemostatic compositions and methods for their preparation
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1297172B1 Methods for producing modified glycoproteins
11/09/2005EP1295127B1 Inter-alpha-trypsin as a marker for sepsis
11/09/2005EP1292673B1 Thrombomodulin analogs for pharmaceutical use
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1209230B1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN
11/09/2005EP1204321B1 Super-active porcine growth hormone releasing hormone analog
11/09/2005EP1141245B1 Somatic cells with ablated prp gene and methods of use
11/09/2005EP1131055B1 Treatment set containing lungsurfactant compositions
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP1075519B1 Inhibitors of nf-kb activation
11/09/2005EP1066041B1 THE USE OF17-ALPHA-ESTRADIOL DERIVATIVES FOR TREATING SIDE-EFFECTS DURING AND/OR AFTER GnRHa THERAPY
11/09/2005EP1036179B1 Method for preparing polypeptides with appropriate glycosilation
11/09/2005EP1029456B1 Foods for preventing vomiting
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005EP0975353B1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
11/09/2005EP0960192B1 Synthetic polynucleotides
11/09/2005EP0950068B1 Collagen binding protein compositions and methods of use
11/09/2005EP0928290B9 Oligoribonucleotides and ribonucleases for cleaving rna
11/09/2005EP0917569B1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
11/09/2005EP0910644B1 Retinoid metabolizing protein
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005EP0842278B1 Dnase-active protein
11/09/2005EP0808330B1 A process for preparing certain aza cyclohexapeptides
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005EP0772455B1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
11/09/2005EP0769024B1 High-affinity melatonin receptors and uses thereof
11/09/2005EP0763111B1 Epil/placentine
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005EP0751958B1 Flucose containing proteoglycan or acid glycan and their pharmaceutical use
11/09/2005EP0750457B1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/09/2005EP0719330B1 Protocadherin proteins and their uses
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694961A Collectin-complement activating protein chimeras
11/09/2005CN1694960A Use of saccharomyces cerevisiae ERG4 mutants for expressing mammalian glucose transporters
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 3163